Last edition
News about "investigational antiseizure medication"
SK Biopharmaceuticals Secures Global Rights to Biohaven's Opakalim for Epilepsy
SK Biopharmaceuticals will gain exclusive global development and commercialisation rights to opakalim, strengthening its epilepsy portfolio alongside cenobamate and advancing its transition to a multi-product global pharma company.
Investigational Antiseizure Medication | 27/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members